Bio & Pharma
Macrogen's GenTok to feature on Samsung Health app
The personalized health management service is set to launch in H1 2025
By Nov 18, 2024 (Gmt+09:00)
1
Min read
Most Read
When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven


Maybe Happy Ending: A robot love story that rewrote Broadway playbook


Samsung steps up AR race with advanced microdisplay for smart glasses


NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen


US auto parts tariffs take effect; Korea avoids heavy hit



South Korea's biotech company Macrogen, Inc. signed a supply agreement to integrate its genome analysis platform, GenTok, into the Samsung Health app.
This initiative aims to popularize genome analysis, only available at specific facilities or health checkup centers.
Samsung Health users can access personalized health management services conveniently through their smartphones.
The GenTok program, exclusively designed for the Samsung Health app, is scheduled for release in the first half of next year.
Genome analysis involves examining the body’s genes from head to toe to assess individual genetic risks for certain diseases.
For example, it can provide insights into genetic predispositions for obesity and muscle development capacity.
Features such as hair loss, sleep, obesity, nutrition, and microbiome analysis are also expected to be integrated with the Samsung Health app.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
-
Corporate investmentLG Electronics breaks ground on $600 mn home appliance plant in India
7 HOURS AGO
-
-
E-commerceCoupang’s Q1 revenue up; quarterly dip signals rising competition
May 07, 2025 (Gmt+09:00)
-
Asset managementKorea Investment & Securities deepens global ties with 2nd IR in New York
May 07, 2025 (Gmt+09:00)
Comment 0
LOG IN